The MEF2c expression was increased in the IPF patient’s pulmonary tissues compared with the normal subjects (Figure 4E), indicating that the study of MOBT targeted MEF2c has clinical value in medical treatment. The gene discussed is MEF2C; the disease is idiopathic pulmonary fibrosis.